Jiashuo Chao
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0002-6578-5967
发表论文 25 篇 · 总被引 572 次 · h-index 12
代表论文
- POSTN + cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 109)
- Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma (2024 · Biomarker Research · 被引 91)
- Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 45)
- Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications. (2020 · PubMed · 被引 42)
- Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma (2023 · International Journal of Radiation Oncology*Biology*Physics · 被引 39)
- Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer (2024 · Biomarker Research · 被引 37)